Regenicell Trademark Details

Regenicell was registered on Tuesday, July 26, 2005 and is currently owned by Garnet Biotherapeutics, Inc. under the registration number 2978173 . This mark is dead with a status of Cancelled - Section 8. The last case file activity for this mark occured 12 years ago on Friday, March 2, 2012, according to the United State Patent & Trademark Office
Word Mark Regenicell
Status Dead Registered 710 — Cancelled - Section 8

Current Owner

Garnet Biotherapeutics, Inc. of Malvern, PA

View all trademarks for Garnet Biotherapeutics, Inc.
Other Trademarks for Garnet Biotherapeutics, Inc.

Previous Owners

Neuronyx Inc of Malvern, PA

View all trademarks for Neuronyx Inc
Other Trademarks for Neuronyx Inc
Serial Number 78099006
Registration Number 2978173
Status Date Friday, March 2, 2012
Filing Date Friday, March 2, 2012
Registration Date Tuesday, July 26, 2005
Attorney Tracy-Gene G. Durkin

Correspondent

Tracy-Gene G. Durkin
Sterne, Kessler, Goldstein & Fox P.L.L.C
1100 New York Avenue, N.W.
Washington DC 20005

Case File Statements

Goods & Services Pharmaceuticals for use in the treatment of neurological, cardiovascular and cancerous diseases and disorders

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 2 — Sec. 8 – Entire Registration
Status Date Friday, March 2, 2012
First Use Anywhere Monday, April 25, 2005
First Use In Commerce Monday, April 25, 2005
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.